Analysis of Characteristics Among Users of Tami, a Digital Companion for Managing Inflammatory Bowel Disease - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Analysis of Characteristics Among Users of Tami, a Digital Companion for Managing Inflammatory Bowel Disease

  • By

  • Ann-Sophie Stratil

  • Benjamin Friedrich

  • Tim Hahn

  • Andreas Lügering

  • Steffeni Papukchieva

  • February 1, 2026

Share

  • 1

    Inflammatory bowel disease (IBD) significantly impacts patients' quality of life and is characterized by gastrointestinal inflammation.

  • 2

    Tami is a digital companion app designed to support IBD patients in Germany by tracking symptoms, medication use, and health-related quality of life.

  • 3

    The study aims to analyze demographic and clinical characteristics of Tami users from June 2023 to December 2024.

  • 4

    Users can report symptoms and patient-reported outcomes (PROs) daily, facilitating personalized treatment strategies and timely interventions.

  • 5

    Data collected through Tami is anonymized and stored securely, complying with GDPR regulations to protect user privacy.

Original Source(s)

Analysis of Characteristics Among Users of Tami, a Digital Companion for Managing Inflammatory Bowel Disease

  • by Ann-Sophie Stratil, Benjamin Friedrich, Tim Hahn, Andreas Lügering, Steffeni Papukchieva

  • February 1, 2026

Related Content

Distinct microbial mediators link diet to inflammation in Crohn’s disease and ulcerative colitis

Risk of Infections With Infliximab vs Adalimumab Among Children With Inflammatory Bowel Disease

Efficacy and safety of upadacitinib for Crohn’s disease in patients in East Asia: a post hoc analysis of randomized phase 3 studies